| Literature DB >> 30214204 |
Marziyeh Hajialyani1, Devesh Tewari2, Eduardo Sobarzo-Sánchez3,4, Seyed Mohammad Nabavi5, Mohammad Hosein Farzaei1, Mohammad Abdollahi6.
Abstract
Wound healing process is an intricate sequence of well-orchestrated biochemical and cellular phenomena to restore the integrity of the skin and subcutaneous tissue. Several plant extracts and their phytoconstituents are known as a promising alternative for wound healing agents due to the presence of diverse active components, ease of access, and their limited side effects. The development of nanotechnological methods can help to improve the efficacy of different therapeutics as well as herbal-based products. Here, we present a review of the efficacy of the plant based-nanomaterials in the management of wounds and discuss the involved therapeutic targets. For this purpose, a profound search has been conducted on in vitro, in vivo, and/or clinical evidences evaluating the efficacy and pharmacological mechanisms of natural product-based nanostructures on different types of wounds. Different pharmacological targets are involved in the wound healing effects of herbal-based nanostructures, including suppressing the production of inflammatory cytokines and inflammatory transduction cascades, reducing oxidative factors and enhancing antioxidative enzymes, and promoting neovascularization and angiogenic pathways through increasing the expression of vascular endothelial growth factor, fibroblast growth factor, and platelet-derived growth factor. Moreover, nanostructure of plant extracts and their phytochemicals can enhance their bioavailability, control their release in the form of sustained delivery systems to the wound site, and enhance the permeability of these therapeutics to the underlying skin layers, which are all necessary for the healing process. Overall, various plant extracts and their natural compounds, used in nanoformulations, have demonstrated high activity in the management of wounds and thus can be assumed as future pharmaceutical drugs.Entities:
Keywords: electrospinning; herbal products; hydrogels; medicinal plants; nanoemulsion; nanofiber; nanomedicine; nanoparticle; nanostructure; natural product; phytochemicals; wound dressing; wound healing
Mesh:
Substances:
Year: 2018 PMID: 30214204 PMCID: PMC6128268 DOI: 10.2147/IJN.S174072
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1Search diagram of study selection.
Figure 2The foremost methods to produce nanoformulations from different natural products.
Abbreviations: DHQ, dihydroquercetin; EGCG, epigallocatechin gallate.
Figure 3The role of natural nanoformulations in different stages of wound healing.
Abbreviations: ECM, extracellular matrix; FGF, fibroblast growth factor; IL, interleukin; PDGF, platelet-derived growth factor; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor; ROS, reactive oxygen species; SOD, superoxide dismutase; CAT, catalase.
Herbal-based nanoformulations used for wound management
| Plant name | Fraction/extraction | Wound healing model | Reference |
|---|---|---|---|
|
| |||
| Electrospinning | |||
| Hydroethanolic extract | In vivo on Sprague Dawley rats | ||
| Tragacanth gum | – | In vivo on Sprague Dawley rats | |
| NM | In vivo on Sprague Dawley rats | ||
| Henna | Leaves ethanolic extract | In vivo on Wistar rats | |
| Fenugreek | Seed extract | In vivo on Wistar rats | |
| Soybean | Protein isolates | In vitro against primary HDFs | |
| Vegetable branch extracts | In vitro against human keratinocytes (HaCaT) | ||
| Bark methanolic extract | In vitro | ||
| Crude extracts | In vitro on NHDF | ||
|
| |||
|
| |||
| Aqueous extract | In vivo (male Wistar albino rats) | ||
| Root aqueous extract | In vivo on Wistar albino rats | ||
| Aqueous extract | In vitro on L929 fibroblast | ||
| Cellulose gum | – | In vivo Sprague Dawley rats | |
| Aqueous root extract | In vivo on albino Wistar rats | ||
| Leaf chloroform extract | In vitro on human keratinocytes | ||
| Leaf aqueous extract | In vivo on Wistar albino rats | ||
| Aqueous extracellular leaf extract | In vivo on Wistar albino rats | ||
| Toluene:ethanol extract | In vitro | ||
| Aqueous leaf extract | In vivo on male albino rats | ||
| Potato starch | – | In vivo on Swiss albino rats | |
| Guar gum | – | In vivo on Wistar rats | |
| Ethanol leaf extract | In vitro | ||
| Turmeric | Acetone extract | In vivo albino rats | |
| Aqueous leaf extract | In vivo on Wistar rats | ||
| Aqueous leaf extract | In vivo on Wistar albino rats | ||
| Fruit peel aqueous extract | In vivo Sprague Dawley rats | ||
| Aqueous leaf extract | In vivo on albino rats | ||
| Aqueous leaf extract | In vivo on rabbits | ||
| Aqueous leaf extract | In vitro | ||
| Methanolic leaf extract | In vivo on albino rats | ||
| Propolis | Propolis:gelucire aqueous extract | In vivo on Wistar rats | |
| Endophytic fungus OC-11 isolate | In vivo Sprague Dawley rats | ||
| Linseed | Linseed hydrogels obtained from aqueous extract | In vitro | |
| Fruit ethanolic extract | In vitro on L929 fibroblast | ||
|
| |||
|
| |||
| Eucalyptus essential oil | In vivo on Sprague Dawley rats | ||
| Aqueous extract | In vitro against human fibroblast cells | ||
| Aqueous extract | In vitro against conjunctival epithelial cells | ||
| NM | In vivo on Swiss albino mice | ||
| Leave extract | In vivo on Swiss albino mice | ||
| Danggui Buxue | Aqueous extract | In vivo on Sprague Dawley rats | |
| Black seed | Essential oil | In vitro against HaCaT cells | |
| Wheat germ | Essential oil | In vitro against HaCaT cells | |
| Leaf ethanolic extract | In vitro against HO-1-N-1 buccal mucosa carcinoma-derived cells | ||
| Tragacanth gum | – | In vitro against human fibroblast cells | |
| Isolated silymarin content | In vivo on male BALB/c mice | ||
| Leaf ethanolic extract | In vivo on CD-1 mice | ||
| Gum arabic | – | In vivo on C57BL6 mice | |
Abbreviations: HDF, human dermal fibroblast; NHDF, normal human dermal fibroblast; NM, not mentioned.
Nanoformulations of different phytochemical compounds used as wound healing agents
| Phytochemical name | Structure | Nanostructure method | Wound healing model | Therapeutic outcomes | Reference |
|---|---|---|---|---|---|
| Emodin |
| Electrospinning (encapsulated in cellulose acetate fiber mats) | In vitro (HDFa) | The nontoxic nature of CA fibers containing emodin between 0.005% and 0.1% wt against HDFa cells (96.8%–87.2% viability) | |
| Electrospinning with PVP | In vivo on mice | promoting fluid retainment and accelerating re-epithelialization of wound in mice | |||
|
| |||||
| EGCG |
| EGCG-loaded nanoliposomes | In vivo on male BALB/c mice | Potent antibacterial activity against | |
|
| |||||
| Dihydroquercetin |
| Nanocomplex with lecithin nanoparticles | In vivo on rats | ↓Wound area | |
|
| |||||
| Curcumin |
| Electrospinning (loaded on CA nanofibers) | In vitro on NHDF | ↑Cell viability | |
| Electrospinning (curcumin/gelatin- blended nanofibrous mats) | In vitro on HS- 27 cells/in vivo on rats | ↑Cell metabolism and proliferation | |||
| Electrospinning (curcumin-loaded gum tragacanth/poly(ε-caprolactone) electrospun nanofibers) | In vivo on rats | ↑Healing rate | |||
| Loading on the collagen functionalized nano-graphene oxide | In vitro against NIH 3T3 embryonic mouse fibroblast/in vivo on the Wistar rats | ↑Cell adhesion due to the high hydrophilicity of scaffold | |||
| Nanocomposite hydrogel (composed of curcumin, | In vivo on rats | ↓Wound area | |||
| Loading the curcumin/Ag nanoparticles on the nanocellulose-dispersed chitosan film | In vivo albino rats | ↓Scars at the closure of wounds | |||
| Chitosan/poly-g-glutamic acid/pluronic/curcumin nanoparticles | In vitro (HSF) In vivo | ↓Inflammation and infection | |||
| Curcumin-loaded polycaprolactone- polyethylene glycol nanofibers | In vitro (on mouse myoblast cell line C2C12) and mouse macrophage cell line RAW264.7/in vivo on female BACB/c | High biocompatibility of scaffold | |||
| Encapsulation in propylene glycol nanoliposomes | In vitro (on HDF) | Considerable recovery rate | |||
| Loading on chitosan- based nanoemulsion gel | In vivo on excisional wounds in Wistar rats | Full wound closure after 12 days | |||
| Loading on gel-core hyaluosomes | In vivo on Sprague Dawley rats | complete healing on day 7 | |||
| Entrapment in hyperbranched polyglycerol electrospun nanofibers | In vivo on rats/in vitro on 3T3 Swiss mouse fibroblast cells | High fibroblast cell adhesion and spreading | |||
| Hydrogel encapsulated in micelles | In vivo on rats | ↑Wound breaking strength | |||
|
| |||||
| Asiaticoside |
| Electrospinning (loaded on the CA nanofibers) | In vitro on NHDF | ↑Cell viability and proliferation rate | |
|
| |||||
| Cellulose acetate |
| Electrospinning (with polyester urethane composite) | In vivo on Wistar rats | Inhibition of the growth of bacteria such as | |
| Electrospinning (with gelatin) | In vitro on NHDF | ↑Proliferation rate of cells | |||
| Electrospinning (with PCL) | In vitro against NIH 3T3 embryonic mouse fibroblast | ↑Growth rate of cells | |||
| Electrospinning (with PLA) | In vivo on BALB-c male mice | ↑Rate of wound closure | |||
| Electrospinning (with zein and polyurethane) | In vitro against 3T3-L1 fibroblasts | ↑Growth rate of cells | |||
| Electrospinning (with gelatin/hydroxyapatite nanocomposite) | In vivo on Wistar rats | ↑Wound closure | |||
Abbreviations: EGCG, epigallocatechin gallate; HDF, human dermal fibroblast; HDFa, human dermal fibroblast adult; HSF, human skin fibroblast; NHDF, normal human dermal fibroblast; PCL, poly (ε-caprolactone); PLA, polylactic acid; PVP, polyvinylpyrrolidone; CA, cellulose acetate.